Published in Cancer Weekly, September 4th, 2001
While the surgery is not considered a failsafe form of protection against certain inherited forms of breast cancer, its efficacy rate is high, and it provides some reassurance for women carrying gene mutations that place them at higher risk for developing the disease. In fact, women with a BRCA1 or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.